You are reading: Healthy Participants | The Resilience Study
Healthy Participants

The Resilience Study

Start date
Nov 11th
Renumeration
$8,100
20 nights, 1 appointment, 1 phone call

Help Test a New Treatment for B-Cell Malignancies

This clinical study is evaluating a new treatment for B-Cell Malignancies. The primary goal is to assess the safety and tolerability of the treatment in healthy adult participants.
Vaccination

Schedule

Cohort 2

20 nights

Check In
Nov 11th
Check Out
Dec 01st
1 phone call
Dec 28th
1 appointment
Dec 07th

To Qualify, You Must

Age
Be 18 to 60 years old
Gender
Both males or females Must be a woman of non-childbearing potential
Physical Condition
Have no significant medical health conditions or allergies
Requirements
Have a BMI between 18 and 32kg/m2
Renumeration
$8,100 *Screening Reimbursement of $100–$250 applies, please see Terms

Help Test a New Treatment for B-Cell Malignancies

Spots are limited. Find out if you qualify today!